Industry Research Reports
Home > Reports > Chemical & Material > Global Pharma Grade L-Alanyl-L-Glutamine Market Insights, Forecast to 2031
Global Pharma Grade L-Alanyl-L-Glutamine Market Insights, Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-06-07
Pages: 141 Pages
Report ld: 4757025
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharma Grade L-Alanyl-L-Glutamine Market Size(US$)
CAGR 2025-2031
5.5%
Market Size,2031
USD 50.9
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 36.9 million
Market Forecast in 2031(Value)
US$ 50.9 million
CAGR
5.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharma Grade L-Alanyl-L-Glutamine market is projected to grow from US$ 36.9 million in 2025 to US$ 50.9 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
In the pharmaceutical industry, L-Alanyl-L-Glutamine is utilized for its role in clinical nutrition and therapeutic formulations. It is particularly beneficial in parenteral nutrition for critically ill patients, helping to maintain muscle mass and improve nitrogen balance. The compound is used to manage conditions associated with muscle wasting, gastrointestinal disorders, and immune dysfunction, offering a reliable means of delivering glutamine in a bioavailable and stable dipeptide form.
The US & Canada market for Pharma Grade L-Alanyl-L-Glutamine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Pharma Grade L-Alanyl-L-Glutamine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Pharma Grade L-Alanyl-L-Glutamine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key manufacturers of Pharma Grade L-Alanyl-L-Glutamine include Ajinomoto, Jinan Chenghui-Shuangda Chemical, Kyowa Hakko Bio, Evonik, Wuhan Microsen Technology, Jiangsu Chengxin Pharmaceutical, Xi’an Lyphar Biotech, Fresenius Kabi, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Pharma Grade L-Alanyl-L-Glutamine production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Pharma Grade L-Alanyl-L-Glutamine by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Pharma Grade L-Alanyl-L-Glutamine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pharma Grade L-Alanyl-L-Glutamine, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pharma Grade L-Alanyl-L-Glutamine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharma Grade L-Alanyl-L-Glutamine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharma Grade L-Alanyl-L-Glutamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharma Grade L-Alanyl-L-Glutamine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ajinomoto, Jinan Chenghui-Shuangda Chemical, Kyowa Hakko Bio, Evonik, Wuhan Microsen Technology, Jiangsu Chengxin Pharmaceutical, Xi’an Lyphar Biotech, Fresenius Kabi, etc.
MARKET SEGMENTATION
By Company
- Ajinomoto
- Jinan Chenghui-Shuangda Chemical
- Kyowa Hakko Bio
- Evonik
- Wuhan Microsen Technology
- Jiangsu Chengxin Pharmaceutical
- Xi’an Lyphar Biotech
- Fresenius Kabi
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Condensation
- Enzymatic Synthesis
- Others
Segment by Application
- Injection
- Tablet
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Pharma Grade L-Alanyl-L-Glutamine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Pharma Grade L-Alanyl-L-Glutamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pharma Grade L-Alanyl-L-Glutamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Grade L-Alanyl-L-Glutamine sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Pharma Grade L-Alanyl-L-Glutamine Product Introduction
1.2 Market by Type
1.2.1 Global Pharma Grade L-Alanyl-L-Glutamine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Condensation
1.2.3 Enzymatic Synthesis
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharma Grade L-Alanyl-L-Glutamine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injection
1.3.3 Tablet
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pharma Grade L-Alanyl-L-Glutamine Production
2.1 Global Pharma Grade L-Alanyl-L-Glutamine Production Capacity (2020-2031)
2.2 Global Pharma Grade L-Alanyl-L-Glutamine Production by Region: 2020 VS 2024 VS 2031
2.3 Global Production by Region
2.3.1 Global Pharma Grade L-Alanyl-L-Glutamine Production by Region (2020-2031)
2.3.2 Global Pharma Grade L-Alanyl-L-Glutamine Production Market Share by Region (2020-2031)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Pharma Grade L-Alanyl-L-Glutamine Revenue Estimates and Forecasts 2020-2031
3.2 Global Revenue by Region
3.2.1 Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Region (2020-2031)
3.2.3 Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Region (2020-2031)
3.3 Global Pharma Grade L-Alanyl-L-Glutamine Sales Estimates and Forecasts 2020-2031
3.4 Global Sales by Region
3.4.1 Global Pharma Grade L-Alanyl-L-Glutamine Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Pharma Grade L-Alanyl-L-Glutamine Sales by Region (2020-2031)
3.4.3 Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Region (2020-2031)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Sales by Manufacturers
4.1.1 Global Pharma Grade L-Alanyl-L-Glutamine Sales by Manufacturers (2020-2025)
4.1.2 Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Manufacturers (2020-2025)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma Grade L-Alanyl-L-Glutamine in 2024
4.2 Global Revenue by Manufacturers
4.2.1 Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Manufacturers (2020-2025)
4.2.2 Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Manufacturers (2020-2025)
4.2.3 Global Top 10 and Top 5 Companies by Pharma Grade L-Alanyl-L-Glutamine Revenue in 2024
4.3 Global Pharma Grade L-Alanyl-L-Glutamine Sales Price by Manufacturers (2020-2025)
4.4 Global Key Players of Pharma Grade L-Alanyl-L-Glutamine, Industry Ranking, 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Pharma Grade L-Alanyl-L-Glutamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Pharma Grade L-Alanyl-L-Glutamine, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Pharma Grade L-Alanyl-L-Glutamine, Product Offered and Application
4.8 Global Key Manufacturers of Pharma Grade L-Alanyl-L-Glutamine, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sales by Type
5.1.1 Global Pharma Grade L-Alanyl-L-Glutamine Historical Sales by Type (2020-2025)
5.1.2 Global Pharma Grade L-Alanyl-L-Glutamine Forecasted Sales by Type (2026-2031)
5.1.3 Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
5.2 Global Revenue by Type
5.2.1 Global Pharma Grade L-Alanyl-L-Glutamine Historical Revenue by Type (2020-2025)
5.2.2 Global Pharma Grade L-Alanyl-L-Glutamine Forecasted Revenue by Type (2026-2031)
5.2.3 Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
5.3 Global Price by Type
5.3.1 Global Pharma Grade L-Alanyl-L-Glutamine Price by Type (2020-2025)
5.3.2 Global Pharma Grade L-Alanyl-L-Glutamine Price Forecast by Type (2026-2031)
6 Market Size by Application
6.1 Global Sales by Application
6.1.1 Global Pharma Grade L-Alanyl-L-Glutamine Historical Sales by Application (2020-2025)
6.1.2 Global Pharma Grade L-Alanyl-L-Glutamine Forecasted Sales by Application (2026-2031)
6.1.3 Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
6.2 Global Revenue by Application
6.2.1 Global Pharma Grade L-Alanyl-L-Glutamine Historical Revenue by Application (2020-2025)
6.2.2 Global Pharma Grade L-Alanyl-L-Glutamine Forecasted Revenue by Application (2026-2031)
6.2.3 Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
6.3 Global Price by Application
6.3.1 Global Pharma Grade L-Alanyl-L-Glutamine Price by Application (2020-2025)
6.3.2 Global Pharma Grade L-Alanyl-L-Glutamine Price Forecast by Application (2026-2031)
7 US & Canada
7.1 US & Canada Market Size by Type
7.1.1 US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2020-2031)
7.1.2 US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2020-2031)
7.2 US & Canada Market Size by Application
7.2.1 US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2020-2031)
7.2.2 US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2020-2031)
7.3 US & Canada Market Size by Country
7.3.1 US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue by Country (2020-2031)
7.3.3 US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales by Country (2020-2031)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Market Size by Type
8.1.1 Europe Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2020-2031)
8.1.2 Europe Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2020-2031)
8.2 Europe Market Size by Application
8.2.1 Europe Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2020-2031)
8.2.2 Europe Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2020-2031)
8.3 Europe Market Size by Country
8.3.1 Europe Pharma Grade L-Alanyl-L-Glutamine Revenue by Country: 2020 VS 2024 VS 2031
8.3.2 Europe Pharma Grade L-Alanyl-L-Glutamine Sales by Country (2020-2031)
8.3.3 Europe Pharma Grade L-Alanyl-L-Glutamine Revenue by Country (2020-2031)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Market Size by Type
9.1.1 China Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2020-2031)
9.1.2 China Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2020-2031)
9.2 China Market Size by Application
9.2.1 China Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2020-2031)
9.2.2 China Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2020-2031)
10 Asia (excluding China)
10.1 Asia Market Size by Type
10.1.1 Asia Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2020-2031)
10.1.2 Asia Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2020-2031)
10.2 Asia Market Size by Application
10.2.1 Asia Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2020-2031)
10.2.2 Asia Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2020-2031)
10.3 Asia Market Size by Region
10.3.1 Asia Pharma Grade L-Alanyl-L-Glutamine Revenue by Region: 2020 VS 2024 VS 2031
10.3.2 Asia Pharma Grade L-Alanyl-L-Glutamine Revenue by Region (2020-2031)
10.3.3 Asia Pharma Grade L-Alanyl-L-Glutamine Sales by Region (2020-2031)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Market Size by Type
11.1.1 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2020-2031)
11.1.2 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2020-2031)
11.2 Middle East, Africa and Latin America Market Size by Application
11.2.1 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2020-2031)
11.2.2 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2020-2031)
11.3 Middle East, Africa and Latin America Market Size by Country
11.3.1 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue by Country: 2020 VS 2024 VS 2031
11.3.2 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue by Country (2020-2031)
11.3.3 Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales by Country (2020-2031)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Ajinomoto
12.1.1 Ajinomoto Corporation Information
12.1.2 Ajinomoto Overview
12.1.3 Ajinomoto Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.4 Ajinomoto Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Ajinomoto Recent Developments
12.2 Jinan Chenghui-Shuangda Chemical
12.2.1 Jinan Chenghui-Shuangda Chemical Corporation Information
12.2.2 Jinan Chenghui-Shuangda Chemical Overview
12.2.3 Jinan Chenghui-Shuangda Chemical Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.4 Jinan Chenghui-Shuangda Chemical Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Jinan Chenghui-Shuangda Chemical Recent Developments
12.3 Kyowa Hakko Bio
12.3.1 Kyowa Hakko Bio Corporation Information
12.3.2 Kyowa Hakko Bio Overview
12.3.3 Kyowa Hakko Bio Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.4 Kyowa Hakko Bio Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Kyowa Hakko Bio Recent Developments
12.4 Evonik
12.4.1 Evonik Corporation Information
12.4.2 Evonik Overview
12.4.3 Evonik Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.4 Evonik Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Evonik Recent Developments
12.5 Wuhan Microsen Technology
12.5.1 Wuhan Microsen Technology Corporation Information
12.5.2 Wuhan Microsen Technology Overview
12.5.3 Wuhan Microsen Technology Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.4 Wuhan Microsen Technology Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Wuhan Microsen Technology Recent Developments
12.6 Jiangsu Chengxin Pharmaceutical
12.6.1 Jiangsu Chengxin Pharmaceutical Corporation Information
12.6.2 Jiangsu Chengxin Pharmaceutical Overview
12.6.3 Jiangsu Chengxin Pharmaceutical Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.4 Jiangsu Chengxin Pharmaceutical Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Jiangsu Chengxin Pharmaceutical Recent Developments
12.7 Xi’an Lyphar Biotech
12.7.1 Xi’an Lyphar Biotech Corporation Information
12.7.2 Xi’an Lyphar Biotech Overview
12.7.3 Xi’an Lyphar Biotech Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.4 Xi’an Lyphar Biotech Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Xi’an Lyphar Biotech Recent Developments
12.8 Fresenius Kabi
12.8.1 Fresenius Kabi Corporation Information
12.8.2 Fresenius Kabi Overview
12.8.3 Fresenius Kabi Pharma Grade L-Alanyl-L-Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.4 Fresenius Kabi Pharma Grade L-Alanyl-L-Glutamine Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Fresenius Kabi Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Pharma Grade L-Alanyl-L-Glutamine Industry Chain Analysis
13.2 Pharma Grade L-Alanyl-L-Glutamine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Pharma Grade L-Alanyl-L-Glutamine Production Mode & Process
13.4 Pharma Grade L-Alanyl-L-Glutamine Sales and Marketing
13.4.1 Pharma Grade L-Alanyl-L-Glutamine Sales Channels
13.4.2 Pharma Grade L-Alanyl-L-Glutamine Distributors
13.5 Pharma Grade L-Alanyl-L-Glutamine Customers
14 Pharma Grade L-Alanyl-L-Glutamine Market Dynamics
14.1 Pharma Grade L-Alanyl-L-Glutamine Industry Trends
14.2 Pharma Grade L-Alanyl-L-Glutamine Market Drivers
14.3 Pharma Grade L-Alanyl-L-Glutamine Market Challenges
14.4 Pharma Grade L-Alanyl-L-Glutamine Market Restraints
15 Key Findings in the Global Pharma Grade L-Alanyl-L-Glutamine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharma Grade L-Alanyl-L-Glutamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Key Manufacturers of Condensation
Table 3. Key Manufacturers of Enzymatic Synthesis
Table 4. Key Manufacturers of Others
Table 5. Global Pharma Grade L-Alanyl-L-Glutamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 6. Global Pharma Grade L-Alanyl-L-Glutamine Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Production by Region (2020-2031) & (Tons)
Table 8. Global Production Market Share by Region (2020-2031)
Table 9. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 10. Global Revenue by Region (2020-2031) & (US$ Million)
Table 11. Global Revenue Market Share by Region (2020-2031)
Table 12. Global Pharma Grade L-Alanyl-L-Glutamine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 13. Global Pharma Grade L-Alanyl-L-Glutamine Sales by Region (2020-2031) & (Tons)
Table 14. Global Sales Market Share by Region (2020-2031)
Table 15. Global Pharma Grade L-Alanyl-L-Glutamine Sales by Manufacturers (2020-2025) & (Tons)
Table 16. Global Pharma Grade L-Alanyl-L-Glutamine Sales Share by Manufacturers (2020-2025)
Table 17. Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 18. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Manufacturers (2020-2025)
Table 19. Pharma Grade L-Alanyl-L-Glutamine Price by Manufacturers (2020-2025) & (US$/Kg)
Table 20. Global Key Players of Pharma Grade L-Alanyl-L-Glutamine, Industry Ranking, 2023 VS 2024
Table 21. Global Pharma Grade L-Alanyl-L-Glutamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pharma Grade L-Alanyl-L-Glutamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Grade L-Alanyl-L-Glutamine as of 2024)
Table 23. Global Key Manufacturers of Pharma Grade L-Alanyl-L-Glutamine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pharma Grade L-Alanyl-L-Glutamine, Product Offered and Application
Table 25. Global Key Manufacturers of Pharma Grade L-Alanyl-L-Glutamine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2020-2025) & (Tons)
Table 28. Global Pharma Grade L-Alanyl-L-Glutamine Sales by Type (2026-2031) & (Tons)
Table 29. Global Sales Share by Type (2020-2031)
Table 30. Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2020-2025) & (US$ Million)
Table 31. Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Type (2026-2031) & (US$ Million)
Table 32. Global Revenue Share by Type (2020-2031)
Table 33. Pharma Grade L-Alanyl-L-Glutamine Price by Type (2020-2025) & (US$/Kg)
Table 34. Global Pharma Grade L-Alanyl-L-Glutamine Price Forecast by Type (2026-2031) & (US$/Kg)
Table 35. Global Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2020-2025) & (Tons)
Table 36. Global Pharma Grade L-Alanyl-L-Glutamine Sales by Application (2026-2031) & (Tons)
Table 37. Global Sales Share by Application (2020-2031)
Table 38. Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2020-2025) & (US$ Million)
Table 39. Global Pharma Grade L-Alanyl-L-Glutamine Revenue by Application (2026-2031) & (US$ Million)
Table 40. Global Revenue Share by Application (2020-2031)
Table 41. Pharma Grade L-Alanyl-L-Glutamine Price by Application (2020-2025) & (US$/Kg)
Table 42. Global Pharma Grade L-Alanyl-L-Glutamine Price Forecast by Application (2026-2031) & (US$/Kg)
Table 43. US & Canada Sales by Type (2020-2031) & (Tons)
Table 44. US & Canada Revenue by Type (2020-2031) & (US$ Million)
Table 45. US & Canada Sales by Application (2020-2031) & (Tons)
Table 46. US & Canada Revenue by Application (2020-2031) & (US$ Million)
Table 47. US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. US & Canada Revenue by Country (2020-2031) & (US$ Million)
Table 49. US & Canada Sales by Country (2020-2031) & (Tons)
Table 50. Europe Sales by Type (2020-2031) & (Tons)
Table 51. Europe Revenue by Type (2020-2031) & (US$ Million)
Table 52. Europe Sales by Application (2020-2031) & (Tons)
Table 53. Europe Revenue by Application (2020-2031) & (US$ Million)
Table 54. Europe Pharma Grade L-Alanyl-L-Glutamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 55. Europe Sales by Country (2020-2031) & (Tons)
Table 56. Europe Revenue by Country (2020-2031) & (US$ Million)
Table 57. China Sales by Type (2020-2031) & (Tons)
Table 58. China Revenue by Type (2020-2031) & (US$ Million)
Table 59. China Sales by Application (2020-2031) & (Tons)
Table 60. China Revenue by Application (2020-2031) & (US$ Million)
Table 61. Asia Sales by Type (2020-2031) & (Tons)
Table 62. Asia Revenue by Type (2020-2031) & (US$ Million)
Table 63. Asia Sales by Application (2020-2031) & (Tons)
Table 64. Asia Revenue by Application (2020-2031) & (US$ Million)
Table 65. Asia Pharma Grade L-Alanyl-L-Glutamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 66. Asia Revenue by Region (2020-2031) & (US$ Million)
Table 67. Asia Sales by Region (2020-2031) & (Tons)
Table 68. Middle East, Africa and Latin America Sales by Type (2020-2031) & (Tons)
Table 69. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
Table 70. Middle East, Africa and Latin America Sales by Application (2020-2031) & (Tons)
Table 71. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
Table 72. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 73. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
Table 74. Middle East, Africa and Latin America Sales by Country (2020-2031) & (Tons)
Table 75. Ajinomoto Corporation Information
Table 76. Ajinomoto Description and Major Businesses
Table 77. Ajinomoto Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Ajinomoto Product Model Numbers, Pictures, Descriptions and Specifications
Table 79. Ajinomoto Recent Developments
Table 80. Jinan Chenghui-Shuangda Chemical Corporation Information
Table 81. Jinan Chenghui-Shuangda Chemical Description and Major Businesses
Table 82. Jinan Chenghui-Shuangda Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. Jinan Chenghui-Shuangda Chemical Product Model Numbers, Pictures, Descriptions and Specifications
Table 84. Jinan Chenghui-Shuangda Chemical Recent Developments
Table 85. Kyowa Hakko Bio Corporation Information
Table 86. Kyowa Hakko Bio Description and Major Businesses
Table 87. Kyowa Hakko Bio Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Kyowa Hakko Bio Product Model Numbers, Pictures, Descriptions and Specifications
Table 89. Kyowa Hakko Bio Recent Developments
Table 90. Evonik Corporation Information
Table 91. Evonik Description and Major Businesses
Table 92. Evonik Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Evonik Product Model Numbers, Pictures, Descriptions and Specifications
Table 94. Evonik Recent Developments
Table 95. Wuhan Microsen Technology Corporation Information
Table 96. Wuhan Microsen Technology Description and Major Businesses
Table 97. Wuhan Microsen Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. Wuhan Microsen Technology Product Model Numbers, Pictures, Descriptions and Specifications
Table 99. Wuhan Microsen Technology Recent Developments
Table 100. Jiangsu Chengxin Pharmaceutical Corporation Information
Table 101. Jiangsu Chengxin Pharmaceutical Description and Major Businesses
Table 102. Jiangsu Chengxin Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Jiangsu Chengxin Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 104. Jiangsu Chengxin Pharmaceutical Recent Developments
Table 105. Xi’an Lyphar Biotech Corporation Information
Table 106. Xi’an Lyphar Biotech Description and Major Businesses
Table 107. Xi’an Lyphar Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. Xi’an Lyphar Biotech Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Xi’an Lyphar Biotech Recent Developments
Table 110. Fresenius Kabi Corporation Information
Table 111. Fresenius Kabi Description and Major Businesses
Table 112. Fresenius Kabi Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Fresenius Kabi Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Fresenius Kabi Recent Developments
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Distributors List
Table 118. Customers List
Table 119. Market Trends
Table 120. Market Drivers
Table 121. Market Challenges
Table 122. Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Grade L-Alanyl-L-Glutamine Product Picture
Figure 2. Global Pharma Grade L-Alanyl-L-Glutamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Pharma Grade L-Alanyl-L-Glutamine Market Share by Type: 2024 & 2031
Figure 4. Condensation Product Picture
Figure 5. Enzymatic Synthesis Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pharma Grade L-Alanyl-L-Glutamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Global Pharma Grade L-Alanyl-L-Glutamine Market Share by Application in 2024 & 2031
Figure 9. Injection
Figure 10. Tablet
Figure 11. Others
Figure 12. Pharma Grade L-Alanyl-L-Glutamine Report Years Considered
Figure 13. Global Pharma Grade L-Alanyl-L-Glutamine Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 14. Global Pharma Grade L-Alanyl-L-Glutamine Production by Region (2020 – 2031) (Tons)
Figure 15. Global Pharma Grade L-Alanyl-L-Glutamine Production Market Share by Region in Percentage: 2024 Versus 2031
Figure 16. Global Pharma Grade L-Alanyl-L-Glutamine Production Market Share by Region (2020-2031)
Figure 17. Pharma Grade L-Alanyl-L-Glutamine Production Growth Rate in North America (2020-2031) & (Tons)
Figure 18. Pharma Grade L-Alanyl-L-Glutamine Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 19. Pharma Grade L-Alanyl-L-Glutamine Production Growth Rate in China (2020-2031) & (Tons)
Figure 20. Pharma Grade L-Alanyl-L-Glutamine Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 21. Global Pharma Grade L-Alanyl-L-Glutamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 23. Global Pharma Grade L-Alanyl-L-Glutamine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Region in Percentage: 2024 Versus 2031
Figure 25. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Region (2020-2031)
Figure 26. Global Pharma Grade L-Alanyl-L-Glutamine Sales (2020-2031) & (Tons)
Figure 27. Global Pharma Grade L-Alanyl-L-Glutamine Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 28. Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Region (2020-2031)
Figure 29. US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales YoY (2020-2031) & (Tons)
Figure 30. US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Pharma Grade L-Alanyl-L-Glutamine Sales YoY (2020-2031) & (Tons)
Figure 32. Europe Pharma Grade L-Alanyl-L-Glutamine Revenue YoY (2020-2031) & (US$ Million)
Figure 33. China Pharma Grade L-Alanyl-L-Glutamine Sales YoY (2020-2031) & (Tons)
Figure 34. China Pharma Grade L-Alanyl-L-Glutamine Revenue YoY (2020-2031) & (US$ Million)
Figure 35. Asia (excluding China) Pharma Grade L-Alanyl-L-Glutamine Sales YoY (2020-2031) & (Tons)
Figure 36. Asia (excluding China) Pharma Grade L-Alanyl-L-Glutamine Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales YoY (2020-2031) & (Tons)
Figure 38. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Global Pharma Grade L-Alanyl-L-Glutamine Sales Share by Manufacturers (2024)
Figure 40. The Pharma Grade L-Alanyl-L-Glutamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 41. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Share by Manufacturers (2024)
Figure 42. The Top 5 and 10 Largest Manufacturers of Pharma Grade L-Alanyl-L-Glutamine in the World: Market Share by Pharma Grade L-Alanyl-L-Glutamine Revenue in 2024
Figure 43. Global Pharma Grade L-Alanyl-L-Glutamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 44. Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
Figure 45. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
Figure 46. Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
Figure 47. Global Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
Figure 48. US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
Figure 49. US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
Figure 50. US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
Figure 51. US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
Figure 52. US & Canada Pharma Grade L-Alanyl-L-Glutamine Revenue Share by Country (2020-2031)
Figure 53. US & Canada Pharma Grade L-Alanyl-L-Glutamine Sales Share by Country (2020-2031)
Figure 54. US Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 55. Canada Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 56. Europe Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
Figure 57. Europe Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
Figure 58. Europe Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
Figure 59. Europe Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
Figure 60. Europe Pharma Grade L-Alanyl-L-Glutamine Sales Share by Country (2020-2031)
Figure 61. Europe Pharma Grade L-Alanyl-L-Glutamine Revenue Share by Country (2020-2031)
Figure 62. Germany Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 63. France Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 64. U.K. Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 65. Italy Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 66. Russia Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 67. China Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
Figure 68. China Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
Figure 69. China Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
Figure 70. China Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
Figure 71. Asia Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
Figure 72. Asia Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
Figure 73. Asia Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
Figure 74. Asia Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
Figure 75. Asia Pharma Grade L-Alanyl-L-Glutamine Revenue Share by Region (2020-2031)
Figure 76. Asia Pharma Grade L-Alanyl-L-Glutamine Sales Share by Region (2020-2031)
Figure 77. Japan Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 78. South Korea Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 79. China Taiwan Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 80. Southeast Asia Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 81. India Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Type (2020-2031)
Figure 83. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Type (2020-2031)
Figure 84. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales Market Share by Application (2020-2031)
Figure 85. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue Market Share by Application (2020-2031)
Figure 86. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Revenue Share by Country (2020-2031)
Figure 87. Middle East, Africa and Latin America Pharma Grade L-Alanyl-L-Glutamine Sales Share by Country (2020-2031)
Figure 88. Brazil Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 89. Mexico Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 90. Turkey Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 91. Israel Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 92. GCC Countries Pharma Grade L-Alanyl-L-Glutamine Revenue (2020-2031) & (US$ Million)
Figure 93. Value Chain
Figure 94. Pharma Grade L-Alanyl-L-Glutamine Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Pharma Grade L-Alanyl-L-Glutamine in 2031?
The global market size of Pharma Grade L-Alanyl-L-Glutamine in 2031 was 50.9 Million USD.
Which companies rank high in the global Pharma Grade L-Alanyl-L-Glutamine market?
Which region is expected to have the highest market share?
What was the global market size of Pharma Grade L-Alanyl-L-Glutamine in 2025?
What is the annual compound growth rate of the global Pharma Grade L-Alanyl-L-Glutamine market size from 2025 to 2031?
Related Reports
Global Pharma Grade L-Alanyl-L-Glutamine Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharma Grade L-Alanyl-L-Glutamine market is projected to grow from US$ 36.89 million in 2025 to US$ 53.38 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 144
USD 4900.00
(Single User License)
Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharma Grade L-Alanyl-L-Glutamine market size was US$ 36.89 million in 2025 and is forecast to reach a readjusted size of US$ 53.38 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 77
USD 4250.00
(Single User License)
Pharma Grade L-Alanyl-L-Glutamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Grade L-Alanyl-L-Glutamine was estimated to be worth US$ 36.89 million in 2025 and is projected to reach US$ 53.38 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 110
USD 3950.00
(Single User License)
Global Pharma Grade L-Alanyl-L-Glutamine Market Research Report 2026
The global Pharma Grade L-Alanyl-L-Glutamine market was valued at US$ 36.89 million in 2025 and is anticipated to reach US$ 53.38 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 128
USD 2900.00
(Single User License)
Global Pharma Grade L-Alanyl-L-Glutamine Market Research Report 2025
The global market for Pharma Grade L-Alanyl-L-Glutamine was valued at US$ 36.0 million in the year 2024 and is projected to reach a revised size of US$ 50.9 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-06-07
Pages: 86
USD 2900.00
(Single User License)
Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Grade L-Alanyl-L-Glutamine market size was US$ 36.0 million in 2024 and is forecast to a readjusted size of US$ 50.9 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-06-07
Pages: 76
USD 4250.00
(Single User License)
Pharma Grade L-Alanyl-L-Glutamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Grade L-Alanyl-L-Glutamine was estimated to be worth US$ 36.0 million in 2024 and is forecast to a readjusted size of US$ 50.9 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-06-07
Pages: 108
USD 3950.00
(Single User License)
Global Pharma Grade L-Alanyl-L-Glutamine Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharma Grade L-Alanyl-L-Glutamine market is projected to grow from US$ 36.89 million in 2025 to US$ 53.38 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 144
USD 4900.00 (Single User License)Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharma Grade L-Alanyl-L-Glutamine market size was US$ 36.89 million in 2025 and is forecast to reach a readjusted size of US$ 53.38 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 77
USD 4250.00 (Single User License)Pharma Grade L-Alanyl-L-Glutamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Grade L-Alanyl-L-Glutamine was estimated to be worth US$ 36.89 million in 2025 and is projected to reach US$ 53.38 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 110
USD 3950.00 (Single User License)Global Pharma Grade L-Alanyl-L-Glutamine Market Research Report 2026
The global Pharma Grade L-Alanyl-L-Glutamine market was valued at US$ 36.89 million in 2025 and is anticipated to reach US$ 53.38 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 128
USD 2900.00 (Single User License)Global Pharma Grade L-Alanyl-L-Glutamine Market Research Report 2025
The global market for Pharma Grade L-Alanyl-L-Glutamine was valued at US$ 36.0 million in the year 2024 and is projected to reach a revised size of US$ 50.9 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-06-07
Pages: 86
USD 2900.00 (Single User License)Global Pharma Grade L-Alanyl-L-Glutamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Grade L-Alanyl-L-Glutamine market size was US$ 36.0 million in 2024 and is forecast to a readjusted size of US$ 50.9 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-06-07
Pages: 76
USD 4250.00 (Single User License)Pharma Grade L-Alanyl-L-Glutamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Grade L-Alanyl-L-Glutamine was estimated to be worth US$ 36.0 million in 2024 and is forecast to a readjusted size of US$ 50.9 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-06-07
Pages: 108
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now